Literature DB >> 23633313

Interventions to improve antibiotic prescribing practices for hospital inpatients.

Peter Davey1, Erwin Brown, Esmita Charani, Lynda Fenelon, Ian M Gould, Alison Holmes, Craig R Ramsay, Philip J Wiffen, Mark Wilcox.   

Abstract

BACKGROUND: The first publication of this review in Issue 3, 2005 included studies up to November 2003. This update adds studies to December 2006 and focuses on application of a new method for meta-analysis of interrupted time series studies and application of new Cochrane Effective Practice and Organisation of Care (EPOC) Risk of Bias criteria to all studies in the review, including those studies in the previously published version. The aim of the review is to evaluate the impact of interventions from the perspective of antibiotic stewardship. The two objectives of antibiotic stewardship are first to ensure effective treatment for patients with bacterial infection and second support professionals and patients to reduce unnecessary use and minimize collateral damage.
OBJECTIVES: To estimate the effectiveness of professional interventions that, alone or in combination, are effective in antibiotic stewardship for hospital inpatients, to evaluate the impact of these interventions on reducing the incidence of antimicrobial-resistant pathogens or Clostridium difficile infection and their impact on clinical outcome. SEARCH
METHODS: We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE from 1980 to December 2006 and the EPOC specialized register in July 2007 and February 2009 and bibliographies of retrieved articles. The main comparison is between interventions that had a restrictive element and those that were purely persuasive. Restrictive interventions were implemented through restriction of the freedom of prescribers to select some antibiotics. Persuasive interventions used one or more of the following methods for changing professional behaviour: dissemination of educational resources, reminders, audit and feedback, or educational outreach. Restrictive interventions could contain persuasive elements. SELECTION CRITERIA: We included randomized clinical trials (RCTs), controlled clinical trials (CCT), controlled before-after (CBA) and interrupted time series studies (ITS). Interventions included any professional or structural interventions as defined by EPOC. The intervention had to include a component that aimed to improve antibiotic prescribing to hospital inpatients, either by increasing effective treatment or by reducing unnecessary treatment. The results had to include interpretable data about the effect of the intervention on antibiotic prescribing or microbial outcomes or relevant clinical outcomes. DATA COLLECTION AND ANALYSIS: Two authors extracted data and assessed quality. We performed meta-regression of ITS studies to compare the results of persuasive and restrictive interventions. Persuasive interventions advised physicians about how to prescribe or gave them feedback about how they prescribed. Restrictive interventions put a limit on how they prescribed; for example, physicians had to have approval from an infection specialist in order to prescribe an antibiotic. We standardized the results of some ITS studies so that they are on the same scale (percent change in outcome), thereby facilitating comparisons of different interventions. To do this, we used the change in level and change in slope to estimate the effect size with increasing time after the intervention (one month, six months, one year, etc) as the percent change in level at each time point. We did not extrapolate beyond the end of data collection after the intervention. The meta-regression was performed using standard weighted linear regression with the standard errors of the coefficients adjusted where necessary. MAIN
RESULTS: For this update we included 89 studies that reported 95 interventions. Of the 89 studies, 56 were ITSs (of which 4 were controlled ITSs), 25 were RCT (of which 5 were cluster-RCTs), 5 were CBAs and 3 were CCTs (of which 1 was a cluster-CCT).Most (80/95, 84%) of the interventions targeted the antibiotic prescribed (choice of antibiotic, timing of first dose and route of administration). The remaining 15 interventions aimed to change exposure of patients to antibiotics by targeting the decision to treat or the duration of treatment. Reliable data about impact on antibiotic prescribing data were available for 76 interventions (44 persuasive, 24 restrictive and 8 structural). For the persuasive interventions, the median change in antibiotic prescribing was 42.3% for the ITSs, 31.6% for the controlled ITSs, 17.7% for the CBAs, 3.5% for the cluster-RCTs and 24.7% for the RCTs. The restrictive interventions had a median effect size of 34.7% for the ITSs, 17.1% for the CBAs and 40.5% for the RCTs. The structural interventions had a median effect of 13.3% for the RCTs and 23.6% for the cluster-RCTs. Data about impact on microbial outcomes were available for 21 interventions but only 6 of these also had reliable data about impact on antibiotic prescribing.Meta-analysis of 52 ITS studies was used to compare restrictive versus purely persuasive interventions. Restrictive interventions had significantly greater impact on prescribing outcomes at one month (32%, 95% confidence interval (CI) 2% to 61%, P = 0.03) and on microbial outcomes at 6 months (53%, 95% CI 31% to 75%, P = 0.001) but there were no significant differences at 12 or 24 months. Interventions intended to decrease excessive prescribing were associated with reduction in Clostridium difficile infections and colonization or infection with aminoglycoside- or cephalosporin-resistant gram-negative bacteria, methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis. Meta-analysis of clinical outcomes showed that four interventions intended to increase effective prescribing for pneumonia were associated with significant reduction in mortality (risk ratio 0.89, 95% CI 0.82 to 0.97), whereas nine interventions intended to decrease excessive prescribing were not associated with significant increase in mortality (risk ratio 0.92, 95% CI 0.81 to 1.06). AUTHORS'
CONCLUSIONS: The results show that interventions to reduce excessive antibiotic prescribing to hospital inpatients can reduce antimicrobial resistance or hospital-acquired infections, and interventions to increase effective prescribing can improve clinical outcome. This update provides more evidence about unintended clinical consequences of interventions and about the effect of interventions to reduce exposure of patients to antibiotics. The meta-analysis supports the use of restrictive interventions when the need is urgent, but suggests that persuasive and restrictive interventions are equally effective after six months.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23633313     DOI: 10.1002/14651858.CD003543.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  225 in total

1.  Implementing an intensified antibiotic stewardship programme targeting daptomycin use in orthopaedic surgery: a cost-benefit analysis from the hospital perspective.

Authors:  Johannes P Borde; Sarah Nussbaum; Stefanie Hauser; Philip Hehn; Johannes Hübner; Gabriela Sitaru; Sebastian Köller; Bruno Schweigert; Katja deWith; Winfried V Kern; Klaus Kaier
Journal:  Infection       Date:  2015-10-16       Impact factor: 3.553

2.  A cross-sectional survey of the profile and activities of Antimicrobial Management Teams in Irish Hospitals.

Authors:  Aoife Fleming; Antonella Tonna; Sile O'Connor; Stephen Byrne; Derek Stewart
Journal:  Int J Clin Pharm       Date:  2014-01-03

3.  Antibiotic stewardship in Germany: a cross-sectional questionnaire survey of 355 intensive care units.

Authors:  F Maechler; F Schwab; C Geffers; E Meyer; R Leistner; P Gastmeier
Journal:  Infection       Date:  2013-10-18       Impact factor: 3.553

4.  A tailored implementation strategy to reduce the duration of intravenous antibiotic treatment in community-acquired pneumonia: a controlled before-and-after study.

Authors:  M F Engel; A H W Bruns; M E J L Hulscher; C A J M Gaillard; S U C Sankatsing; F Teding van Berkhout; M H Emmelot-Vonk; E M Kuck; M H M Steeghs; J H den Breeijen; R K Stellato; A I M Hoepelman; J J Oosterheert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-26       Impact factor: 3.267

Review 5.  Management of diverticular disease.

Authors:  Roland H Pfützer; Wolfgang Kruis
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-07-14       Impact factor: 46.802

6.  Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention.

Authors:  Loria A Pollack; Arjun Srinivasan
Journal:  Clin Infect Dis       Date:  2014-10-15       Impact factor: 9.079

Review 7.  Point-of-prescription interventions to improve antimicrobial stewardship.

Authors:  Keith W Hamilton; Jeffrey S Gerber; Rebekah Moehring; Deverick J Anderson; Michael S Calderwood; Jennifer H Han; Jimish M Mehta; Lori A Pollack; Theoklis Zaoutis; Arjun Srinivasan; Bernard C Camins; David N Schwartz; Ebbing Lautenbach
Journal:  Clin Infect Dis       Date:  2015-01-16       Impact factor: 9.079

8.  Impact of the medical specialty on knowledge regarding multidrug-resistant organisms and strategies toward antimicrobial stewardship.

Authors:  Steffen Lebentrau; Christian Gilfrich; Malte W Vetterlein; Harald Schumacher; Philipp J Spachmann; Sabine D Brookman-May; Hans M Fritsche; Martin Schostak; Florian M Wagenlehner; Maximilian Burger; Matthias May
Journal:  Int Urol Nephrol       Date:  2017-04-21       Impact factor: 2.370

Review 9.  Understanding Clostridium difficile Colonization.

Authors:  Monique J T Crobach; Jonathan J Vernon; Vivian G Loo; Ling Yuan Kong; Séverine Péchiné; Mark H Wilcox; Ed J Kuijper
Journal:  Clin Microbiol Rev       Date:  2018-03-14       Impact factor: 26.132

10.  Adherence of Newborn-Specific Antibiotic Stewardship Programs to CDC Recommendations.

Authors:  Timmy Ho; Madge E Buus-Frank; Erika M Edwards; Kate A Morrow; Karla Ferrelli; Arjun Srinivasan; Daniel A Pollock; Dmitry Dukhovny; John A F Zupancic; DeWayne M Pursley; Roger F Soll; Jeffrey D Horbar
Journal:  Pediatrics       Date:  2018-12       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.